Companies

See how salaries can vary from company to company

We are Future. A global specialist multi-media platform that creates loyal communities across a portfolio of over 200 compelling brands. Every month we engage with over 400 million people globally through websites, events and magazines, with our content reaching 1 in 3 adults online in both UK & the US. Founded in 1985, we have grown significantly to a global business over over 2,000 colleagues. We are the largest magazine publisher in the UK with a combined circulation of more than 3 million across our publications. We haven't just survived in 2020, we've thrived, increasing our audience shar... view company details

Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer vaccines. The company uses its proprietary discovery platform, ATLAS, to recall a patient's pre-existing CD4+ and CD8+ T cell immune responses to tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. Its lead immuno-oncology program is GEN-009, an adjuvanted neoantigen peptide vaccine candidate, which is in preclinical stage, designed to direct a patient's immune system to attack tumor. The company is also seeking partners to develop... view company details

GTY Technology Holdings Inc. provides cloud-based suite of solutions for state and local governments in North America. The company develops software technologies for the procurement and vendor or supplier sourcing industry in government, public sector, and various highly-regulated commercial vertical markets; content, digital, and integrated payment services via a software-as-a-service platform for government agencies and utility companies. It also develops cloud-based grants management and cost allocation software for state, local, and tribal governments; software to streamline municipal perm... view company details

Gaia, Inc. operates a digital video subscription service and online community that caters underserved subscriber base worldwide. The company has a digital content library of approximately 8,000 titles available to its subscribers on Internet-connected devices. Its subscribers have access to a library of films, documentaries, interviews, yoga classes, transformation related content, and others for digital streaming. The company's content on its network is curated into four channels, including Yoga, Transformation, Alternative Healing, and Seeking Truth; and delivered directly to subscribers thr... view company details

Gevo, Inc., a renewable chemicals and low-carbon fuel company, focuses on the development and commercialization of renewable alternatives to petroleum-based products in the United States. It operates through two segments, Gevo, Inc. and Gevo Development/Agri-Energy. The company engages in the research, development, and production of isobutanol; development of its proprietary biocatalysts; production and sale of renewable jet and other fuels; and retrofit process of chemicals and biofuels. It is also involved in the production of ethanol, isobutanol, and related products. In addition, the compa... view company details

The Beginning... DALLAS - April 16, 2019 - Milestone Management, one of the largest residential property management firms, announced today the rebranding of the company to Highmark Residential in order to better reflect its commitment to delivering unmatched levels of service across all channels. The rebranding will take place in stages throughout the course of 2019, with a full transition expected across all systems in early 2020. Taking a cue from its name, Highmark Residential will continue to build upon the company's legacy of dedication to providing the highest level of service to residen... view company details

Interpace Diagnostics Group, Inc. develops and commercializes molecular diagnostic tests to detect genetic alterations associated with gastrointestinal, endocrine, and lung cancers. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that helps physicians better assess risk of pancreaticobiliary cancers using its proprietary PathFinderTG platform; ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules; ThyraMIR, an microRNA gene expression assay that helps to classify risk of cancer in thyroid nodules; and RespriDx, a genomic test to ... view company details

Inuvo, Inc., together with its subsidiaries, a technology company, provides data-driven platforms that automatically identify and message online audiences across video, mobile, connected TV, display, and social and native devices, channels, and formats in the United States. The company's digital marketplace allows advertisers and publishers the opportunity to buy and sell advertising space in real time. Its products and services include ValidClick, a software as a service and delivery platform for publishers that offers a pay-per-click solution where advertisements are targeted to consumers ba... view company details

iStar Inc. (NYSE: STAR) is focused on reinventing the ground lease sector, unlocking value for real estate owners throughout the country by providing modern, more efficient ground leases on all types of properties. As the founder, investment manager and largest shareholder of Safehold Inc. (NYSE: SAFE), the first publicly traded company to focus on modern ground leases, iStar is helping create a logical new approach to the way real estate is owned, and continues to use its historic strengths in finance and net lease to expand this unique platform. Recognized as a consistent innovator in the re... view company details

Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company offers vopratelimab, a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors, which is in Phase I/II clinical trial for the treatment of head and neck squamous cell cancer, non-small cell lung cancer, triple negative breast cancer, gastric cancer, and other tumor types identified through its translational science platform. It is also developing JTX-4014, a mon... view company details

Kennedy-Wilson Holdings, Inc. operates as a real estate investment company. The company owns, operates, and invests in real estate both on its own and through its investment management platform. It focuses on multifamily and commercial properties located in the Western United States, the United Kingdom, Ireland, Spain, Italy, and Japan. The company owns interest in approximately 53 million square feet of property, including 28,613 multifamily rental units; and 18.9 million square feet of commercial property. It also provides real estate services primarily to financial services clients. In addi... view company details

Limelight Networks, Inc. provides content delivery and related services and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers services and solutions for businesses to deliver their digital content across Internet, mobile, social, and other digital initiatives. It operates edge services platform that provides content delivery services, video content management services, performance services for Website and Web application acceleration and security, professional services, cloud storage, and edge computing services, as well as sells equipment. Th... view company details

LiveRamp Holdings, Inc. provides identity and data connectivity for powering exceptional customer experiences. The company offers IdentityLink, an identity resolution platform that connects people, data, and devices across the physical and digital world, powering privacy-compliant, people-based marketing that allows consumers to better connect with the brands and products they love. It also provides AbiliTec, an offline PII resolution technology that gives platforms and the marketers they work with the ability to connect and update what they know about consumers, resolve PII data across enterp... view company details

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company focusing on the development of antibody drug conjugate (ADC) for cancer patients with unmet need. The company develops Dolaflexin, a platform, which is used to generate a pipeline of proprietary ADC product candidates to address patient populations that are not amenable to treat with traditional ADC-based therapies. Its lead product candidate is XMT-1536, a Dolaflexin ADC targeting NaPi2b that is in Phase I clinical trial for the treatment of patients with ovarian cancer, non small cell lung cancer, and other orphan indicat... view company details

CUSTOMER EXPERIENCE. OUR PASSION. We are proud to partner with multi-location businesses, providing a wide array of customer experience management solutions, analytics and reporting technology. Our solutions help our clients protect their brand reputation, delight customers and make more money. Solutions include customer experience surveys, mystery shopping, contact center services and social media review data integrated on one technology and analytics platform. Founded in 2005, Market Force has a growing global presence, with offices in the United States, Canada, United Kingdom, France and Sp... view company details

MC3 solutions are specifically tuned to address the strategic business objectives of global pharmaceutical, biotechnology, and medical devices companies. MC3 takes pride in working with companies of all sizes, including top 10 global, mid-size and emerging specialty companies. For over 15 years, MC3 has created custom training & development programs and enduring sales and product launch meeting experiences. Our tailored solutions, which are developed using contemporary learning strategies and enabled by the latest technologies, enhance learner engagement and retention. At MC3, we leverage the ... view company details

OrCam harnesses the power of artificial vision to assist people who are visually impaired. OrCam has created a technologically advanced device unique in its ability to provide visual aid through a discreet wearable platform and simple easy-to-use interface which serves to enhance the daily lives of people with vision loss. OrCam gives independence. Developed by leading minds in the Computer Vision and Machine Learning field, our team includes dedicated software, computer and electrical engineers, hardware design experts, and a first rate customer service team, which we're proud to say includes... view company details

The seemingly endless number of EdTech solutions on the market are making the lives of educators, students, and parents more chaotic. And, while over 93% of teachers are using technology, more than 2/3rds of them are unsatisfied with the effectiveness of their tools. Meanwhile, school administrators have limited visibility into the student performance data being gathered by these tools and are unable to make timely evidence-based decisions. Otus brings the entire school community together on a common technology platform reducing the number of disconnected solutions educators use while providin... view company details

PAID, Inc. develops online shipping and tax management tools. It operates through four segments: Client Services, Shipping Calculator Services, Brewery Management Software, and Shipping Coordination and Label Generation Services. The company offers AuctionInc, a suite of online shipping and tax management tools, which assists businesses with e-commerce storefronts, shipping solutions, tax calculation, inventory management, and auction processing. It also provides BeerRun, a brewery management, and alcohol and tobacco tax and trade bureau tax reporting software to small craft brewers. In additi... view company details

PharmaCyte Biotech, Inc., a clinical stage biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cance... view company details